{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:22:22Z","timestamp":1794406942394,"version":"4.9.0"},"reference-count":243,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41568-025-00879-8","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:36:14Z","timestamp":1760520974000},"page":"27-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Exploiting metabolic cell death for cancer therapy"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-8539","authenticated-orcid":false,"given":"Chao","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-3908","authenticated-orcid":false,"given":"Dadi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9824-1643","authenticated-orcid":false,"given":"Albert C.","family":"Koong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8884-6040","authenticated-orcid":false,"given":"Boyi","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"879_CR1","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.cell.2011.10.033","volume":"147","author":"Y Fuchs","year":"2011","unstructured":"Fuchs, Y. & Steller, H. Programmed cell death in animal development and disease. Cell 147, 742\u2013758 (2011).","journal-title":"Cell"},{"key":"879_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"879_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death Differ."},{"key":"879_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135\u2013147 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"879_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239\u2013257 (1972).","journal-title":"Br. J. Cancer"},{"key":"879_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cdd.2017.186","volume":"25","author":"J Kale","year":"2018","unstructured":"Kale, J., Osterlund, E. J. & Andrews, D. W. BCL-2 family proteins: changing partners in the dance towards death. Cell Death Differ. 25, 65\u201380 (2018).","journal-title":"Cell Death Differ."},{"key":"879_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-1910(65)90099-5","volume":"11","author":"RA Lockshin","year":"1965","unstructured":"Lockshin, R. A. & Williams, C. M. Programmed cell death-I. Cytology of degeneration in the intersegmental muscles of the Pernyi silkmoth. J. Insect Physiol. 11, 123\u2013133 (1965).","journal-title":"J. Insect Physiol."},{"key":"879_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112\u2013119 (2005).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","volume":"9","author":"BT Cookson","year":"2001","unstructured":"Cookson, B. T. & Brennan, M. A. Pro-inflammatory programmed cell death. Trends Microbiol. 9, 113\u2013114 (2001).","journal-title":"Trends Microbiol."},{"key":"879_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1242\/jcs.03349","volume":"120","author":"S Jin","year":"2007","unstructured":"Jin, S., DiPaola, R. S., Mathew, R. & White, E. Metabolic catastrophe as a means to cancer cell death. J. Cell Sci. 120, 379\u2013383 (2007).","journal-title":"J. Cell Sci."},{"key":"879_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012). The foundational paper that introduced the concept of ferroptosis.","journal-title":"Cell"},{"key":"879_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022). The seminal study that first defined and characterized cuproptosis as a distinctive form of regulated cell death triggered by copper overload.","journal-title":"Science"},{"key":"879_CR13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell Biol. 25, 404\u2013414 (2023). The original study that established disulfidptosis as a unique form of cell death driven by disulfide stress.","journal-title":"Nat. Cell Biol."},{"key":"879_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.tcb.2012.08.008","volume":"22","author":"DR Green","year":"2012","unstructured":"Green, D. R. & Victor, B. The pantheon of the fallen: why are there so many forms of cell death? Trends Cell Biol. 22, 555\u2013556 (2012).","journal-title":"Trends Cell Biol."},{"key":"879_CR15","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.devcel.2024.08.008","volume":"59","author":"DR Green","year":"2024","unstructured":"Green, D. R. Cell death: revisiting the roads to ruin. Dev. Cell 59, 2523\u20132531 (2024).","journal-title":"Dev. Cell"},{"key":"879_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei, G., Zhuang, L. & Gan, B. Targeting ferroptosis as a vulnerability in cancer. Nat. Rev. Cancer 22, 381\u2013396 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"879_CR17","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"879_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon, S. J. & Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 25, 424\u2013442 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"879_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang, D., Kroemer, G. & Kang, R. Targeting cuproplasia and cuproptosis in cancer. Nat. Rev. Clin. Oncol. 21, 370\u2013388 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"879_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","volume":"34","author":"X Liu","year":"2024","unstructured":"Liu, X., Zhuang, L. & Gan, B. Disulfidptosis: disulfide stress-induced cell death. Trends Cell Biol. 34, 327\u2013337 (2024).","journal-title":"Trends Cell Biol."},{"key":"879_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42, 513\u2013534 (2024).","journal-title":"Cancer Cell"},{"key":"879_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X., Kang, R., Kroemer, G. & Tang, D. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18, 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"879_CR23","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos, A. F., Fazeli, G., Xavier da Silva, T. N. & Friedmann Angeli, J. P. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 33, 1062\u20131076 (2023).","journal-title":"Trends Cell Biol."},{"key":"879_CR24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","volume":"26","author":"E Dai","year":"2024","unstructured":"Dai, E. et al. A guideline on the molecular ecosystem regulating ferroptosis. Nat. Cell Biol. 26, 1447\u20131457 (2024).","journal-title":"Nat. Cell Biol."},{"key":"879_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. & Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 26, 165\u2013176 (2016).","journal-title":"Trends Cell Biol."},{"key":"879_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon, S. J. et al. Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death. ACS Chem. Biol. 10, 1604\u20131609 (2015).","journal-title":"ACS Chem. Biol."},{"key":"879_CR28","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen, X., Yu, C., Kang, R. & Tang, D. Iron metabolism in ferroptosis. Front. Cell Dev. Biol. 8, 590226 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"879_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-024-02088-5","volume":"10","author":"F Alves","year":"2025","unstructured":"Alves, F., Lane, D., Nguyen, T. P. M., Bush, A. I. & Ayton, S. In defence of ferroptosis. Signal Transduct. Target. Ther. 10, 2 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"879_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao, M. et al. Role of mitochondria in ferroptosis. Mol. Cell 73, 354\u2013363.e3 (2019).","journal-title":"Mol. Cell"},{"key":"879_CR31","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202105043","volume":"220","author":"B Gan","year":"2021","unstructured":"Gan, B. Mitochondrial regulation of ferroptosis. J. Cell Biol. 220, e202105043 (2021).","journal-title":"J. Cell Biol."},{"key":"879_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat. Cell Biol. 22, 225\u2013234 (2020).","journal-title":"Nat. Cell Biol."},{"key":"879_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-020-00297-2","volume":"5","author":"C Li","year":"2020","unstructured":"Li, C. et al. LKB1\u2013AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis. Signal Transduct. Target. Ther. 5, 187 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"879_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1021\/acschembio.8b00199","volume":"13","author":"MM Gaschler","year":"2018","unstructured":"Gaschler, M. M. et al. Determination of the subcellular localization and mechanism of action of ferrostatins in suppressing ferroptosis. ACS Chem. Biol. 13, 1013\u20131020 (2018).","journal-title":"ACS Chem. Biol."},{"key":"879_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong, L. et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem. Biol. 26, 420\u2013432.e9 (2019).","journal-title":"Cell Chem. Biol."},{"key":"879_CR36","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","volume":"79","author":"L Tesfay","year":"2019","unstructured":"Tesfay, L. et al. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 79, 5355\u20135366 (2019).","journal-title":"Cancer Res."},{"key":"879_CR37","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang, D. et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186, 2748\u20132764.e22 (2023).","journal-title":"Cell"},{"key":"879_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014). This study identifies GPX4 as the major suppressive mechanism of ferroptosis.","journal-title":"Cell"},{"key":"879_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng, H. & Stockwell, B. R. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol. 16, e2006203 (2018).","journal-title":"PLoS Biol."},{"key":"879_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019).","journal-title":"Nature"},{"key":"879_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"879_CR42","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao, C. et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593, 586\u2013590 (2021).","journal-title":"Nature"},{"key":"879_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121987119","volume":"119","author":"S Wu","year":"2022","unstructured":"Wu, S. et al. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria. Proc. Natl Acad. Sci. USA 119, e2121987119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"879_CR44","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.cmet.2023.06.014","volume":"35","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metab. 35, 1474\u20131490.e8 (2023).","journal-title":"Cell Metab."},{"key":"879_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft, V. A. N. et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent. Sci. 6, 41\u201353 (2020).","journal-title":"ACS Cent. Sci."},{"key":"879_CR46","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351\u20131360 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR47","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti, S. V. & Torti, F. M. Iron and cancer: more ore to be mined. Nat. Rev. Cancer 13, 342\u2013355 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"879_CR48","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","volume":"27","author":"BR Stockwell","year":"2020","unstructured":"Stockwell, B. R. & Jiang, X. The chemistry and biology of ferroptosis. Cell Chem. Biol. 27, 365\u2013375 (2020).","journal-title":"Cell Chem. Biol."},{"key":"879_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.mam.2005.07.015","volume":"26","author":"JY Uriu-Adams","year":"2005","unstructured":"Uriu-Adams, J. Y. & Keen, C. L. Copper, oxidative stress, and human health. Mol. Aspects Med. 26, 268\u2013298 (2005).","journal-title":"Mol. Aspects Med."},{"key":"879_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen, L., Min, J. & Wang, F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct. Target. Ther. 7, 378 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"879_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge, E. J. et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat. Rev. Cancer 22, 102\u2013113 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"879_CR52","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov, P. et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat. Chem. Biol. 15, 681\u2013689 (2019). This study proposes that elesclomol-induced cell death represents a unique form of copper-dependent cell death, laying the groundwork for the subsequent discovery of cuproptosis.","journal-title":"Nat. Chem. Biol."},{"key":"879_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.tibs.2024.04.002","volume":"49","author":"CH Lin","year":"2024","unstructured":"Lin, C. H. et al. Protein lipoylation: mitochondria, cuproptosis, and beyond. Trends Biochem. Sci. 49, 729\u2013744 (2024).","journal-title":"Trends Biochem. Sci."},{"key":"879_CR54","doi-asserted-by":"publisher","first-page":"7522","DOI":"10.1074\/jbc.TM117.000259","volume":"293","author":"A Solmonson","year":"2018","unstructured":"Solmonson, A. & DeBerardinis, R. J. Lipoic acid metabolism and mitochondrial redox regulation. J. Biol. Chem. 293, 7522\u20137530 (2018).","journal-title":"J. Biol. Chem."},{"key":"879_CR55","doi-asserted-by":"publisher","first-page":"105046","DOI":"10.1016\/j.jbc.2023.105046","volume":"299","author":"MB Dreishpoon","year":"2023","unstructured":"Dreishpoon, M. B. et al. FDX1 regulates cellular protein lipoylation through direct binding to LIAS. J. Biol. Chem. 299, 105046 (2023).","journal-title":"J. Biol. Chem."},{"key":"879_CR56","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz, V. et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat. Chem. Biol. 19, 206\u2013217 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR57","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","volume":"43","author":"G Lei","year":"2025","unstructured":"Lei, G. et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell 43, 1076\u20131092.e1075 (2025). This study reveals that radiotherapy induces cuproptosis and proposes the use of cuproptosis inducers as a therapeutic strategy to overcome radioresistance.","journal-title":"Cancer Cell"},{"key":"879_CR58","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang, Z. et al. Hypoxia inducible factor-1alpha drives cancer resistance to cuproptosis. Cancer Cell 43, 937\u2013954.e9 (2025).","journal-title":"Cancer Cell"},{"key":"879_CR59","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","volume":"31","author":"YT Liu","year":"2024","unstructured":"Liu, Y. T. et al. Dysregulated Wnt\/beta-catenin signaling confers resistance to cuproptosis in cancer cells. Cell Death Differ. 31, 1452\u20131466 (2024).","journal-title":"Cell Death Differ."},{"key":"879_CR60","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.xcrm.2023.101264","volume":"4","author":"T Xing","year":"2023","unstructured":"Xing, T. et al. Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma. Cell Rep. Med. 4, 101264 (2023).","journal-title":"Cell Rep. Med."},{"key":"879_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023).","journal-title":"Nat. Commun."},{"key":"879_CR62","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai, M. et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic. Biol. Med. 52, 2142\u20132150 (2012).","journal-title":"Free Radic. Biol. Med."},{"key":"879_CR63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jinorgbio.2014.04.004","volume":"137","author":"BB Hasinoff","year":"2014","unstructured":"Hasinoff, B. B., Yadav, A. A., Patel, D. & Wu, X. The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II). J. Inorg. Biochem. 137, 22\u201330 (2014).","journal-title":"J. Inorg. Biochem."},{"key":"879_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.32604\/or.2023.028694","volume":"31","author":"Y Gan","year":"2023","unstructured":"Gan, Y. et al. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways. Oncol. Res. 31, 333\u2013343 (2023).","journal-title":"Oncol. Res."},{"key":"879_CR65","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10565-024-09857-6","volume":"40","author":"H Yi","year":"2024","unstructured":"Yi, H. et al. Retinoic acid mitigates the NSC319726-induced spermatogenesis dysfunction through cuproptosis-independent mechanisms. Cell Biol. Toxicol. 40, 26 (2024).","journal-title":"Cell Biol. Toxicol."},{"key":"879_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04533-5","volume":"21","author":"M Tarin","year":"2023","unstructured":"Tarin, M., Babaie, M., Eshghi, H., Matin, M. M. & Saljooghi, A. S. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications. J. Transl. Med. 21, 745 (2023).","journal-title":"J. Transl. Med."},{"key":"879_CR67","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ccell.2025.04.013","volume":"43","author":"D Dang","year":"2025","unstructured":"Dang, D. et al. Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis. Cancer Cell 43, 1159\u20131174.e8 (2025).","journal-title":"Cancer Cell"},{"key":"879_CR68","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/bjc.2013.534","volume":"109","author":"P Liu","year":"2013","unstructured":"Liu, P. et al. Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. Br. J. Cancer 109, 1876\u20131885 (2013).","journal-title":"Br. J. Cancer"},{"key":"879_CR69","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1021\/jm049568z","volume":"47","author":"D Cen","year":"2004","unstructured":"Cen, D., Brayton, D., Shahandeh, B., Meyskens, F. L. Jr. & Farmer, P. J. Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J. Med. Chem. 47, 6914\u20136920 (2004).","journal-title":"J. Med. Chem."},{"key":"879_CR70","doi-asserted-by":"publisher","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","volume":"66","author":"D Chen","year":"2006","unstructured":"Chen, D., Cui, Q. C., Yang, H. & Dou, Q. P. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 66, 10425\u201310433 (2006).","journal-title":"Cancer Res."},{"key":"879_CR71","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/bjc.2012.442","volume":"107","author":"P Liu","year":"2012","unstructured":"Liu, P. et al. Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br. J. Cancer 107, 1488\u20131497 (2012).","journal-title":"Br. J. Cancer"},{"key":"879_CR72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2009.09.002","volume":"290","author":"X Guo","year":"2010","unstructured":"Guo, X. et al. Disulfiram\/copper complex inhibiting NF\u03baB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines. Cancer Lett. 290, 104\u2013113 (2010).","journal-title":"Cancer Lett."},{"key":"879_CR73","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-15-1798","volume":"22","author":"X Lun","year":"2016","unstructured":"Lun, X. et al. Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma. Clin. Cancer Res. 22, 3860\u20133875 (2016).","journal-title":"Clin. Cancer Res."},{"key":"879_CR74","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ijrobp.2024.05.009","volume":"120","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. A phase 1\/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma. Int. J. Radiat. Oncol. Biol. Phys. 120, 738\u2013749 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"879_CR75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.chembiol.2018.02.010","volume":"25","author":"K Shimada","year":"2018","unstructured":"Shimada, K. et al. Copper-binding small molecule induces oxidative stress and cell-cycle arrest in glioblastoma-patient-derived cells. Cell Chem. Biol. 25, 585\u2013594.e7 (2018).","journal-title":"Cell Chem. Biol."},{"key":"879_CR76","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu, J. J. et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat. Immunol. 21, 736\u2013745 (2020).","journal-title":"Nat. Immunol."},{"key":"879_CR77","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trsl.2023.09.007","volume":"264","author":"Z Zhuang","year":"2024","unstructured":"Zhuang, Z., Gu, J., Li, B. O. & Yang, L. Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction. Transl. Res. 264, 66\u201375 (2024).","journal-title":"Transl. Res."},{"key":"879_CR78","doi-asserted-by":"publisher","first-page":"114609","DOI":"10.1016\/j.celrep.2024.114609","volume":"43","author":"J Xu","year":"2024","unstructured":"Xu, J., Pickard, J. M. & Nunez, G. FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation. Cell Rep. 43, 114609 (2024).","journal-title":"Cell Rep."},{"key":"879_CR79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12, 599\u2013620 (2021).","journal-title":"Protein Cell"},{"key":"879_CR80","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","volume":"274","author":"H Sato","year":"1999","unstructured":"Sato, H., Tamba, M., Ishii, T. & Bannai, S. Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455\u201311458 (1999).","journal-title":"J. Biol. Chem."},{"key":"879_CR81","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","volume":"22","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. Nat. Cell Biol. 22, 476\u2013486 (2020). This work demonstrates that SLC7A11-high cancer cells are vulnerable to disulfide stress under glucose starvation, laying the groundwork for the subsequent discovery of disulfidptosis.","journal-title":"Nat. Cell Biol."},{"key":"879_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15074","volume":"8","author":"CS Shin","year":"2017","unstructured":"Shin, C. S. et al. The glutamate\/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat. Commun. 8, 15074 (2017).","journal-title":"Nat. Commun."},{"key":"879_CR83","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/S0021-9258(17)49891-7","volume":"295","author":"JH Joly","year":"2020","unstructured":"Joly, J. H., Delfarah, A., Phung, P. S., Parrish, S. & Graham, N. A. A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose. J. Biol. Chem. 295, 1350\u20131365 (2020).","journal-title":"J. Biol. Chem."},{"key":"879_CR84","doi-asserted-by":"publisher","first-page":"19721","DOI":"10.1074\/jbc.M117.814392","volume":"292","author":"T Goji","year":"2017","unstructured":"Goji, T., Takahara, K., Negishi, M. & Katoh, H. Cystine uptake through the cystine\/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation. J. Biol. Chem. 292, 19721\u201319732 (2017).","journal-title":"J. Biol. Chem."},{"key":"879_CR85","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1074\/jbc.M117.798405","volume":"292","author":"P Koppula","year":"2017","unstructured":"Koppula, P., Zhang, Y., Shi, J., Li, W. & Gan, B. The glutamate\/cystine antiporter SLC7A11\/xCT enhances cancer cell dependency on glucose by exporting glutamate. J. Biol. Chem. 292, 14240\u201314249 (2017).","journal-title":"J. Biol. Chem."},{"key":"879_CR86","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/onc.2010.466","volume":"30","author":"N El Mjiyad","year":"2011","unstructured":"El Mjiyad, N., Caro-Maldonado, A., Ramirez-Peinado, S. & Munoz-Pinedo, C. Sugar-free approaches to cancer cell killing. Oncogene 30, 253\u2013264 (2011).","journal-title":"Oncogene"},{"key":"879_CR87","doi-asserted-by":"publisher","first-page":"102711","DOI":"10.1016\/j.redox.2023.102711","volume":"63","author":"Z Zhong","year":"2023","unstructured":"Zhong, Z. et al. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors. Redox Biol. 63, 102711 (2023).","journal-title":"Redox Biol."},{"key":"879_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39401-9","volume":"14","author":"Y Yan","year":"2023","unstructured":"Yan, Y. et al. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells. Nat. Commun. 14, 3673 (2023).","journal-title":"Nat. Commun."},{"key":"879_CR89","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41418-024-01440-0","volume":"32","author":"M Tang","year":"2025","unstructured":"Tang, M. et al. Inhibition of thioredoxin reductase 1 sensitizes glucose-starved glioblastoma cells to disulfidptosis. Cell Death Differ. 32, 598\u2013612 (2025).","journal-title":"Cell Death Differ."},{"key":"879_CR90","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/cancers14133059","volume":"14","author":"S Li","year":"2022","unstructured":"Li, S. et al. The role of SLC7A11 in cancer: friend or foe? Cancers 14, 3059 (2022).","journal-title":"Cancers"},{"key":"879_CR91","doi-asserted-by":"publisher","first-page":"1438807","DOI":"10.3389\/fimmu.2024.1438807","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang, Y. & Sun, M. SLC7A11: the Achilles heel of tumor? Front. Immunol. 15, 1438807 (2024).","journal-title":"Front. Immunol."},{"key":"879_CR92","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.isci.2021.102649","volume":"24","author":"P Koppula","year":"2021","unstructured":"Koppula, P. et al. KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition. iScience 24, 102649 (2021).","journal-title":"iScience"},{"key":"879_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202408789","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Inhibition of endoplasmic reticulum stress cooperates with SLC7A11 to promote disulfidptosis and suppress tumor growth upon glucose limitation. Adv. Sci. 12, e2408789 (2024).","journal-title":"Adv. Sci."},{"key":"879_CR94","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G. & Galluzzi, L. Mitochondrial metabolism and cancer. Cell Res. 28, 265\u2013280 (2018).","journal-title":"Cell Res."},{"key":"879_CR95","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.cell.2024.04.037","volume":"187","author":"A Suomalainen","year":"2024","unstructured":"Suomalainen, A. & Nunnari, J. Mitochondria at the crossroads of health and disease. Cell 187, 2601\u20132627 (2024).","journal-title":"Cell"},{"key":"879_CR96","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.freeradbiomed.2024.07.006","volume":"223","author":"X Song","year":"2024","unstructured":"Song, X., Hao, X. & Zhu, B. T. Role of mitochondrial reactive oxygen species in chemically-induced ferroptosis. Free Radic. Biol. Med. 223, 473\u2013492 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"879_CR97","doi-asserted-by":"publisher","first-page":"107678","DOI":"10.1016\/j.jbc.2024.107678","volume":"300","author":"S Miyahara","year":"2024","unstructured":"Miyahara, S. et al. FDX2, an iron\u2013sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells. J. Biol. Chem. 300, 107678 (2024).","journal-title":"J. Biol. Chem."},{"key":"879_CR98","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez, S. W. et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551, 639\u2013643 (2017).","journal-title":"Nature"},{"key":"879_CR99","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.molcel.2024.04.009","volume":"84","author":"C Mao","year":"2024","unstructured":"Mao, C. et al. Unraveling ETC complex I function in ferroptosis reveals a potential ferroptosis-inducing therapeutic strategy for LKB1-deficient cancers. Mol. Cell 84, 1964\u20131979.e6 (2024).","journal-title":"Mol. Cell"},{"key":"879_CR100","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrm3909","volume":"16","author":"TA Rouault","year":"2015","unstructured":"Rouault, T. A. Mammalian iron\u2013sulphur proteins: novel insights into biogenesis and function. Nat. Rev. Mol. Cell Biol. 16, 45\u201355 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"879_CR101","doi-asserted-by":"publisher","first-page":"736837","DOI":"10.1155\/2012\/736837","volume":"2012","author":"VI Lushchak","year":"2012","unstructured":"Lushchak, V. I. Glutathione homeostasis and functions: potential targets for medical interventions. J. Amino Acids 2012, 736837 (2012).","journal-title":"J. Amino Acids"},{"key":"879_CR102","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue, Q. et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy 19, 1982\u20131996 (2023).","journal-title":"Autophagy"},{"key":"879_CR103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-021-04025-w","volume":"599","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells. Nature 599, 136\u2013140 (2021).","journal-title":"Nature"},{"key":"879_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30126-9","volume":"13","author":"X Shi","year":"2022","unstructured":"Shi, X. et al. Combinatorial GxGxE CRISPR screen identifies SLC25A39 in mitochondrial glutathione transport linking iron homeostasis to OXPHOS. Nat. Commun. 13, 2483 (2022).","journal-title":"Nat. Commun."},{"key":"879_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-81317-x","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism. Sci. Rep. 14, 29579 (2024).","journal-title":"Sci. Rep."},{"key":"879_CR106","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol. 20, 1181\u20131192 (2018).","journal-title":"Nat. Cell Biol."},{"key":"879_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00535-0","volume":"13","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Tumor suppressor BAP1 suppresses disulfidptosis through the regulation of SLC7A11 and NADPH levels. Oncogenesis 13, 31 (2024).","journal-title":"Oncogenesis"},{"key":"879_CR108","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","volume":"57","author":"HN Bell","year":"2024","unstructured":"Bell, H. N., Stockwell, B. R. & Zou, W. Ironing out the role of ferroptosis in immunity. Immunity 57, 941\u2013956 (2024).","journal-title":"Immunity"},{"key":"879_CR109","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"879_CR110","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378.e6 (2022). Together with Wang et al. (2019), this study shows that IFN\u03b3 released by CD8+ T cells can promote ferroptosis in cancer cells via downregulating SLC7A11 expression and upregulating ACSL4 levels.","journal-title":"Cancer Cell"},{"key":"879_CR111","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang, X. et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 9, 1673\u20131685 (2019).","journal-title":"Cancer Discov."},{"key":"879_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19193-y","volume":"11","author":"PP Yee","year":"2020","unstructured":"Yee, P. P. et al. Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat. Commun. 11, 5424 (2020).","journal-title":"Nat. Commun."},{"key":"879_CR113","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang, R. et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J. Hematol. Oncol. 13, 110 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"879_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang, R. et al. HMGB1 in health and disease. Mol. Aspects Med. 40, 1\u2013116 (2014).","journal-title":"Mol. Aspects Med."},{"key":"879_CR115","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s40425-019-0826-3","volume":"7","author":"VD Turubanova","year":"2019","unstructured":"Turubanova, V. D. et al. Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. J. Immunother. Cancer 7, 350 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"879_CR116","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2019.01.090","volume":"510","author":"Q Wen","year":"2019","unstructured":"Wen, Q., Liu, J., Kang, R., Zhou, B. & Tang, D. The release and activity of HMGB1 in ferroptosis. Biochem. Biophys. Res. Commun. 510, 278\u2013283 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"879_CR117","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051162","volume":"22","author":"J Song","year":"2021","unstructured":"Song, J. et al. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity. EMBO Rep. 22, e51162 (2021).","journal-title":"EMBO Rep."},{"key":"879_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17380-5","volume":"11","author":"B Yu","year":"2020","unstructured":"Yu, B., Choi, B., Li, W. & Kim, D. H. Magnetic field boosted ferroptosis-like cell death and responsive MRI using hybrid vesicles for cancer immunotherapy. Nat. Commun. 11, 3637 (2020).","journal-title":"Nat. Commun."},{"key":"879_CR119","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41418-020-00719-2","volume":"28","author":"X Luo","year":"2021","unstructured":"Luo, X. et al. Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2. Cell Death Differ. 28, 1971\u20131989 (2021).","journal-title":"Cell Death Differ."},{"key":"879_CR120","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia, B. et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J. Clin. Invest. 128, 3341\u20133355 (2018).","journal-title":"J. Clin. Invest."},{"key":"879_CR121","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","volume":"129","author":"W Li","year":"2019","unstructured":"Li, W. et al. Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation. J. Clin. Invest. 129, 2293\u20132304 (2019).","journal-title":"J. Clin. Invest."},{"key":"879_CR122","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro, E., Demuynck, R., Naessens, F., Galluzzi, L. & Krysko, D. V. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer 10, 407\u2013416 (2024).","journal-title":"Trends Cancer"},{"key":"879_CR123","doi-asserted-by":"publisher","first-page":"2127273","DOI":"10.1080\/2162402X.2022.2127273","volume":"11","author":"O Kepp","year":"2022","unstructured":"Kepp, O. & Kroemer, G. Is ferroptosis immunogenic? The devil is in the details! Oncoimmunology 11, 2127273 (2022).","journal-title":"Oncoimmunology"},{"key":"879_CR124","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova, I. et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J. Immunother. Cancer 8, e001369 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"879_CR125","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","volume":"8","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi, L. et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J. Immunother. Cancer 8, e000337 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"879_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki, B. et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat. Commun. 13, 3676 (2022).","journal-title":"Nat. Commun."},{"key":"879_CR127","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612, 338\u2013346 (2022). This study reports that ferroptosis in tumour neutrophil can elicit an immunosuppressive effect in cancer cells.","journal-title":"Nature"},{"key":"879_CR128","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2020.1714209","volume":"16","author":"E Dai","year":"2020","unstructured":"Dai, E. et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy 16, 2069\u20132083 (2020).","journal-title":"Autophagy"},{"key":"879_CR129","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai, E. et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat. Commun. 11, 6339 (2020).","journal-title":"Nat. Commun."},{"key":"879_CR130","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"879_CR131","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561\u20131577.e7 (2021).","journal-title":"Immunity"},{"key":"879_CR132","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli, J. P., Krysko, D. V. & Conrad, M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405\u2013414 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"879_CR133","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol. 188, 21\u201328 (2012).","journal-title":"J. Immunol."},{"key":"879_CR134","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP Bottcher","year":"2018","unstructured":"Bottcher, J. P. et al. NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172, 1022\u20131037.e14 (2018).","journal-title":"Cell"},{"key":"879_CR135","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","volume":"36","author":"D Wang","year":"2015","unstructured":"Wang, D. & DuBois, R. N. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 36, 1085\u20131093 (2015).","journal-title":"Carcinogenesis"},{"key":"879_CR136","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/s41556-025-01673-2","volume":"27","author":"J Wan","year":"2025","unstructured":"Wan, J. et al. Lactate dehydrogenase B facilitates disulfidptosis and exhaustion of tumour-infiltrating CD8+ T cells. Nat. Cell Biol. 27, 972\u2013982 (2025). This study shows that disulfidptosis in tumour-infiltrating CD8+ T cells promotes CD8+ T cell exhaustion and impairs antitumour immunity.","journal-title":"Nat. Cell Biol."},{"key":"879_CR137","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1021\/acsomega.2c07052","volume":"8","author":"XX Wang","year":"2023","unstructured":"Wang, X. X. et al. Cuproptosis-mediated patterns characterized by distinct tumor microenvironment and predicted the immunotherapy response for gastric cancer. ACS Omega 8, 10851\u201310862 (2023).","journal-title":"ACS Omega"},{"key":"879_CR138","first-page":"6026","volume":"15","author":"J Mi","year":"2023","unstructured":"Mi, J. et al. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. Am. J. Transl. Res. 15, 6026\u20136041 (2023).","journal-title":"Am. J. Transl. Res."},{"key":"879_CR139","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10142-023-01210-0","volume":"23","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma. Funct. Integr. Genom. 23, 279 (2023).","journal-title":"Funct. Integr. Genom."},{"key":"879_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45761-5","volume":"13","author":"JH Wu","year":"2023","unstructured":"Wu, J. H. et al. Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. Sci. Rep. 13, 18390 (2023).","journal-title":"Sci. Rep."},{"key":"879_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43835-y","volume":"13","author":"P Zhang","year":"2023","unstructured":"Zhang, P. et al. DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. Sci. Rep. 13, 17295 (2023).","journal-title":"Sci. Rep."},{"key":"879_CR142","doi-asserted-by":"publisher","first-page":"12314","DOI":"10.18632\/aging.205181","volume":"15","author":"S Huang","year":"2023","unstructured":"Huang, S. et al. Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification. Aging 15, 12314\u201312329 (2023).","journal-title":"Aging"},{"key":"879_CR143","doi-asserted-by":"publisher","first-page":"175909142110375","DOI":"10.1177\/17590914211037505","volume":"13","author":"ZQ Bu","year":"2021","unstructured":"Bu, Z. Q. et al. Emerging role of ferroptosis in the pathogenesis of ischemic stroke: a new therapeutic target? ASN Neuro 13, 17590914211037505 (2021).","journal-title":"ASN Neuro"},{"key":"879_CR144","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao, M., Monian, P., Quadri, N., Ramasamy, R. & Jiang, X. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 59, 298\u2013308 (2015).","journal-title":"Mol. Cell"},{"key":"879_CR145","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X. et al. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl Acad. Sci. USA 116, 2672\u20132680 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"879_CR146","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen, J., Li, X., Ge, C., Min, J. & Wang, F. The multifaceted role of ferroptosis in liver disease. Cell Death Differ. 29, 467\u2013480 (2022).","journal-title":"Cell Death Differ."},{"key":"879_CR147","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/mmr.2021.11864","volume":"23","author":"L Luo","year":"2021","unstructured":"Luo, L., Mo, G. & Huang, D. Ferroptosis in hepatic ischemia\u2013reperfusion injury: regulatory mechanisms and new methods for therapy (Review). Mol. Med. Rep. 23, 225 (2021).","journal-title":"Mol. Med. Rep."},{"key":"879_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48330-0","volume":"15","author":"D Jiang","year":"2024","unstructured":"Jiang, D. et al. IRE1alpha determines ferroptosis sensitivity through regulation of glutathione synthesis. Nat. Commun. 15, 4114 (2024).","journal-title":"Nat. Commun."},{"key":"879_CR149","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1021\/jacs.8b01462","volume":"140","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Quantitative profiling of protein carbonylations in ferroptosis by an aniline-derived probe. J. Am. Chem. Soc. 140, 4712\u20134720 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"879_CR150","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","volume":"16","author":"JK Eaton","year":"2020","unstructured":"Eaton, J. K. et al. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles. Nat. Chem. Biol. 16, 497\u2013506 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR151","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang, W. S. et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc. Natl Acad. Sci. USA 113, E4966\u2013E4975 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"879_CR152","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1158\/2159-8290.CD-23-1220","volume":"14","author":"G Lei","year":"2024","unstructured":"Lei, G. et al. BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers. Cancer Discov. 14, 1476\u20131495 (2024).","journal-title":"Cancer Discov."},{"key":"879_CR153","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453\u2013457 (2017).","journal-title":"Nature"},{"key":"879_CR154","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551, 247\u2013250 (2017). This study, together with Lei et al. (2024) and Viswanathan et al. (2017), shows that certain therapy-resistant cancer cells or those with loss of certain tumour suppressors (such as BRCA1) are vulnerable to ferroptosis.","journal-title":"Nature"},{"key":"879_CR155","doi-asserted-by":"publisher","first-page":"858462","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana, N., Ta, K. T. & DelGiorno, K. E. The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front. Oncol. 12, 858462 (2022).","journal-title":"Front. Oncol."},{"key":"879_CR156","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.1073\/pnas.0502856102","volume":"102","author":"S Chintala","year":"2005","unstructured":"Chintala, S. et al. Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells. Proc. Natl Acad. Sci. USA 102, 10964\u201310969 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"879_CR157","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1523\/JNEUROSCI.5465-10.2011","volume":"31","author":"D De Bundel","year":"2011","unstructured":"De Bundel, D. et al. Loss of system xc\u2013 does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility. J. Neurosci. 31, 5792\u20135803 (2011).","journal-title":"J. Neurosci."},{"key":"879_CR158","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI124049","volume":"130","author":"K Hu","year":"2020","unstructured":"Hu, K. et al. Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. J. Clin. Invest. 130, 1752\u20131766 (2020).","journal-title":"J. Clin. Invest."},{"key":"879_CR159","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda, N. et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864\u2013868 (2007).","journal-title":"Nature"},{"key":"879_CR160","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"A Ala","year":"2007","unstructured":"Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S. & Schilsky, M. L. Wilson\u2019s disease. Lancet 369, 397\u2013408 (2007).","journal-title":"Lancet"},{"key":"879_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301088","volume":"10","author":"K Zeng","year":"2023","unstructured":"Zeng, K. et al. Inhibition of CDK1 overcomes oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in colorectal cancer. Adv. Sci. 10, e2301088 (2023).","journal-title":"Adv. Sci."},{"key":"879_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38753-6","volume":"14","author":"M Zhan","year":"2023","unstructured":"Zhan, M. et al. Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase. Nat. Commun. 14, 3123 (2023).","journal-title":"Nat. Commun."},{"key":"879_CR163","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","volume":"381","author":"JL Roh","year":"2016","unstructured":"Roh, J. L., Kim, E. H., Jang, H. J., Park, J. Y. & Shin, D. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett. 381, 96\u2013103 (2016).","journal-title":"Cancer Lett."},{"key":"879_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30217-7","volume":"13","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nat. Commun. 13, 2672 (2022).","journal-title":"Nat. Commun."},{"key":"879_CR165","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1158\/0008-5472.CAN-23-0285","volume":"83","author":"R Sun","year":"2023","unstructured":"Sun, R. et al. Androgen receptor variants confer castration resistance in prostate cancer by counteracting antiandrogen-induced ferroptosis. Cancer Res. 83, 3192\u20133204 (2023).","journal-title":"Cancer Res."},{"key":"879_CR166","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.drup.2023.100985","volume":"70","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resist. Updat. 70, 100985 (2023).","journal-title":"Drug Resist. Updat."},{"key":"879_CR167","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1038\/s41388-021-01790-w","volume":"40","author":"G Lei","year":"2021","unstructured":"Lei, G. et al. Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity. Oncogene 40, 3533\u20133547 (2021).","journal-title":"Oncogene"},{"key":"879_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula, P. et al. A targetable CoQ\u2013FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat. Commun. 13, 2206 (2022).","journal-title":"Nat. Commun."},{"key":"879_CR169","doi-asserted-by":"publisher","first-page":"102626","DOI":"10.1016\/j.redox.2023.102626","volume":"60","author":"K Jiang","year":"2023","unstructured":"Jiang, K. et al. STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma. Redox Biol. 60, 102626 (2023).","journal-title":"Redox Biol."},{"key":"879_CR170","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei, G. et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 30, 146\u2013162 (2020).","journal-title":"Cell Res."},{"key":"879_CR171","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.jhep.2022.01.009","volume":"76","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. COMMD10 inhibits HIF1\u03b1\/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu\u2013Fe balance in hepatocellular carcinoma. J. Hepatol. 76, 1138\u20131150 (2022).","journal-title":"J. Hepatol."},{"key":"879_CR172","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang, Z. et al. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J. Clin. Invest. 131, e139434 (2021).","journal-title":"J. Clin. Invest."},{"key":"879_CR173","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-16-1979","volume":"77","author":"S Zhu","year":"2017","unstructured":"Zhu, S. et al. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 77, 2064\u20132077 (2017).","journal-title":"Cancer Res."},{"key":"879_CR174","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1021\/acschembio.9b00939","volume":"15","author":"LF Ye","year":"2020","unstructured":"Ye, L. F. et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem. Biol. 15, 469\u2013484 (2020).","journal-title":"ACS Chem. Biol."},{"key":"879_CR175","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi, J., Zhu, J., Wu, J., Thompson, C. B. & Jiang, X. Oncogenic activation of PI3K\u2013AKT\u2013mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc. Natl Acad. Sci. USA 117, 31189\u201331197 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"879_CR176","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hep.28574","volume":"64","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 64, 488\u2013500 (2016).","journal-title":"Hepatology"},{"key":"879_CR177","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Han, F., Du, Y., Shi, H. & Zhou, W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct. Target. Ther. 8, 70 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"879_CR178","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41565-024-01784-1","volume":"19","author":"Y Liao","year":"2024","unstructured":"Liao, Y. et al. A cuproptosis nanocapsule for cancer radiotherapy. Nat. Nanotechnol. 19, 1892\u20131902 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"879_CR179","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1016070230538","volume":"74","author":"DR Budman","year":"2002","unstructured":"Budman, D. R. & Calabro, A. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines. Breast Cancer Res. Treat. 74, 41\u201346 (2002).","journal-title":"Breast Cancer Res. Treat."},{"key":"879_CR180","first-page":"2679","volume":"32","author":"A O\u2019Brien","year":"2012","unstructured":"O\u2019Brien, A., Barber, J. E., Reid, S., Niknejad, N. & Dimitroulakos, J. Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3. Anticancer Res. 32, 2679\u20132688 (2012).","journal-title":"Anticancer Res."},{"key":"879_CR181","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2967\/jnumed.112.113324","volume":"54","author":"C Rae","year":"2013","unstructured":"Rae, C. et al. The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells. J. Nucl. Med. 54, 953\u2013960 (2013).","journal-title":"J. Nucl. Med."},{"key":"879_CR182","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","volume":"20","author":"H Nechushtan","year":"2015","unstructured":"Nechushtan, H. et al. A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer. Oncologist 20, 366\u2013367 (2015).","journal-title":"Oncologist"},{"key":"879_CR183","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s10637-022-01271-1","volume":"40","author":"M Mego","year":"2022","unstructured":"Mego, M. et al. Phase II study of disulfiram and cisplatin in refractory germ cell tumors. The GCT-SK-006 phase II trial. Invest. N. Drugs 40, 1080\u20131086 (2022).","journal-title":"Invest. N. Drugs"},{"key":"879_CR184","doi-asserted-by":"publisher","first-page":"102091","DOI":"10.1016\/j.tranon.2024.102091","volume":"49","author":"K Zhang","year":"2024","unstructured":"Zhang, K. et al. Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance. Transl. Oncol. 49, 102091 (2024).","journal-title":"Transl. Oncol."},{"key":"879_CR185","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235\u2013256 (2024).","journal-title":"Cell"},{"key":"879_CR186","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379\u2013395 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"879_CR187","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","volume":"30","author":"H Feng","year":"2020","unstructured":"Feng, H. et al. Transferrin receptor is a specific ferroptosis marker. Cell Rep. 30, 3411\u20133423.e7 (2020).","journal-title":"Cell Rep."},{"key":"879_CR188","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","volume":"83","author":"S Cui","year":"2023","unstructured":"Cui, S. et al. Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases. Mol. Cell 83, 3931\u20133939.e5 (2023).","journal-title":"Mol. Cell"},{"key":"879_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53135-2","volume":"15","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. Intermetallics triggering pyroptosis and disulfidptosis in cancer cells promote anti-tumor immunity. Nat. Commun. 15, 8696 (2024).","journal-title":"Nat. Commun."},{"key":"879_CR190","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon, S. J. et al. Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 3, e02523 (2014).","journal-title":"eLife"},{"key":"879_CR191","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173\u2013184 (2016).","journal-title":"Hepatology"},{"key":"879_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma, S., Henson, E. S., Chen, Y. & Gibson, S. B. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 7, e2307 (2016).","journal-title":"Cell Death Dis."},{"key":"879_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06042-1","volume":"14","author":"SY Park","year":"2023","unstructured":"Park, S. Y. et al. Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer. Cell Death Dis. 14, 532 (2023).","journal-title":"Cell Death Dis."},{"key":"879_CR194","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/or.2023.8584","volume":"50","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Artesunate synergistically promotes sorafenib-induced apoptosis and ferroptosis in non-Hodgkin lymphoma cells through inhibition of the STAT3 pathway. Oncol. Rep. 50, 147 (2023).","journal-title":"Oncol. Rep."},{"key":"879_CR195","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41401-020-0478-3","volume":"42","author":"ZJ Li","year":"2021","unstructured":"Li, Z. J. et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol. Sin. 42, 301\u2013310 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"879_CR196","doi-asserted-by":"publisher","first-page":"517","DOI":"10.18632\/oncoscience.160","volume":"2","author":"N Eling","year":"2015","unstructured":"Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A. & Brady, N. R. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2, 517\u2013532 (2015).","journal-title":"Oncoscience"},{"key":"879_CR197","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ. 29, 2190\u20132202 (2022).","journal-title":"Cell Death Differ."},{"key":"879_CR198","doi-asserted-by":"publisher","first-page":"870178","DOI":"10.3389\/fphar.2022.870178","volume":"13","author":"Z Zhou","year":"2022","unstructured":"Zhou, Z. et al. Cisplatin promotes the efficacy of immune checkpoint inhibitor therapy by inducing ferroptosis and activating neutrophils. Front. Pharmacol. 13, 870178 (2022).","journal-title":"Front. Pharmacol."},{"key":"879_CR199","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo, J. et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res. Treat. 50, 445\u2013460 (2018).","journal-title":"Cancer Res. Treat."},{"key":"879_CR200","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-22-3971","volume":"29","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. The DRD2 antagonist haloperidol mediates autophagy-induced ferroptosis to increase temozolomide sensitivity by promoting endoplasmic reticulum stress in glioblastoma. Clin. Cancer Res. 29, 3172\u20133188 (2023).","journal-title":"Clin. Cancer Res."},{"key":"879_CR201","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1080\/15548627.2020.1739447","volume":"17","author":"C Li","year":"2021","unstructured":"Li, C. et al. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death. Autophagy 17, 948\u2013960 (2021).","journal-title":"Autophagy"},{"key":"879_CR202","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jare.2023.08.018","volume":"62","author":"LP Zhao","year":"2024","unstructured":"Zhao, L. P. et al. \u03b2-Elemene induced ferroptosis via TFEB-mediated GPX4 degradation in EGFR wide-type non-small cell lung cancer. J. Adv. Res. 62, 257\u2013272 (2024).","journal-title":"J. Adv. Res."},{"key":"879_CR203","first-page":"23","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19\/miR-19b-3p\/FTH1 axis. Bioact. Mater. 13, 23\u201336 (2022).","journal-title":"Bioact. Mater."},{"key":"879_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22471-y","volume":"12","author":"A Beatty","year":"2021","unstructured":"Beatty, A. et al. Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat. Commun. 12, 2244 (2021).","journal-title":"Nat. Commun."},{"key":"879_CR205","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","volume":"22","author":"E Ooko","year":"2015","unstructured":"Ooko, E. et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine 22, 1045\u20131054 (2015).","journal-title":"Phytomedicine"},{"key":"879_CR206","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3349\/ymj.2021.62.9.843","volume":"62","author":"Q Song","year":"2021","unstructured":"Song, Q., Peng, S., Sun, Z., Heng, X. & Zhu, X. Temozolomide drives ferroptosis via a DMT1-dependent pathway in glioblastoma cells. Yonsei Med. J. 62, 843\u2013849 (2021).","journal-title":"Yonsei Med. J."},{"key":"879_CR207","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nchembio.2079","volume":"12","author":"K Shimada","year":"2016","unstructured":"Shimada, K. et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis. Nat. Chem. Biol. 12, 497\u2013503 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR208","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12951-021-01058-1","volume":"19","author":"X Yao","year":"2021","unstructured":"Yao, X. et al. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J. Nanobiotechnol. 19, 311 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"879_CR209","doi-asserted-by":"publisher","first-page":"eabl8920","DOI":"10.1126\/sciadv.abl8920","volume":"8","author":"A von Massenhausen","year":"2022","unstructured":"von Massenhausen, A. et al. Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion. Sci. Adv. 8, eabl8920 (2022).","journal-title":"Sci. Adv."},{"key":"879_CR210","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cell.2015.05.056","volume":"162","author":"JH Woo","year":"2015","unstructured":"Woo, J. H. et al. Elucidating compound mechanism of action by network perturbation analysis. Cell 162, 441\u2013451 (2015).","journal-title":"Cell"},{"key":"879_CR211","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem. Biol. 26, 623\u2013633.e9 (2019).","journal-title":"Cell Chem. Biol."},{"key":"879_CR212","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234\u2013245 (2008).","journal-title":"Chem. Biol."},{"key":"879_CR213","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.bmcl.2011.09.047","volume":"22","author":"M Weiwer","year":"2012","unstructured":"Weiwer, M. et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg. Med. Chem. Lett. 22, 1822\u20131826 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"879_CR214","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/ml200195s","volume":"3","author":"WS Yang","year":"2012","unstructured":"Yang, W. S. et al. Identification of simple compounds with microtubule-binding activity that inhibit cancer cell growth with high potency. ACS Med. Chem. Lett. 3, 35\u201338 (2012).","journal-title":"ACS Med. Chem. Lett."},{"key":"879_CR215","doi-asserted-by":"publisher","DOI":"10.1172\/JCI166647","volume":"133","author":"ME Wang","year":"2023","unstructured":"Wang, M. E. et al. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F\/ACSL4 axis. J. Clin. Invest. 133, e166647 (2023).","journal-title":"J. Clin. Invest."},{"key":"879_CR216","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1021\/acschembio.2c00028","volume":"17","author":"H Yoshioka","year":"2022","unstructured":"Yoshioka, H. et al. Identification of a small molecule that enhances ferroptosis via inhibition of ferroptosis suppressor protein 1 (FSP1). ACS Chem. Biol. 17, 483\u2013491 (2022).","journal-title":"ACS Chem. Biol."},{"key":"879_CR217","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.chembiol.2023.04.007","volume":"30","author":"JM Hendricks","year":"2023","unstructured":"Hendricks, J. M. et al. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem. Biol. 30, 1090\u20131103.e7 (2023).","journal-title":"Cell Chem. Biol."},{"key":"879_CR218","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-21-0728","volume":"21","author":"J Li","year":"2022","unstructured":"Li, J. et al. Small-molecule MMRi62 induces ferroptosis and inhibits metastasis in pancreatic cancer via degradation of ferritin heavy chain and mutant p53. Mol. Cancer Ther. 21, 535\u2013545 (2022).","journal-title":"Mol. Cancer Ther."},{"key":"879_CR219","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1016\/0006-2952(85)90026-7","volume":"34","author":"B Johansson","year":"1985","unstructured":"Johansson, B. & Stankiewicz, Z. Bis-(diethyldithiocarbamato) copper complex: a new metabolite of disulfiram? Biochem. Pharmacol. 34, 2989\u20132991 (1985).","journal-title":"Biochem. Pharmacol."},{"key":"879_CR220","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0773.1979.tb02358.x","volume":"45","author":"J Aaseth","year":"1979","unstructured":"Aaseth, J., Soli, N. E. & Forre, O. Increased brain uptake of copper and zinc in mice caused by diethyldithiocarbamate. Acta Pharmacol. Toxicol. 45, 41\u201344 (1979).","journal-title":"Acta Pharmacol. Toxicol."},{"key":"879_CR221","first-page":"197","volume":"1","author":"D Cen","year":"2002","unstructured":"Cen, D. et al. Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol. Cancer Ther. 1, 197\u2013204 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"879_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.04.013","volume":"126","author":"AA Yadav","year":"2013","unstructured":"Yadav, A. A., Patel, D., Wu, X. & Hasinoff, B. B. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II). J. Inorg. Biochem. 126, 1\u20136 (2013).","journal-title":"J. Inorg. Biochem."},{"key":"879_CR223","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1016\/j.bmcl.2013.07.032","volume":"23","author":"S Chen","year":"2013","unstructured":"Chen, S. et al. Syntheses and antitumor activities of N\u20321,N\u20323-dialkyl-N\u20321,N\u20323-di-(alkylcarbonothioyl) malonohydrazide: the discovery of elesclomol. Bioorg. Med. Chem. Lett. 23, 5070\u20135076 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"879_CR224","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1078-0432.CCR-06-0964","volume":"13","author":"A Berkenblit","year":"2007","unstructured":"Berkenblit, A. et al. Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors. Clin. Cancer Res. 13, 584\u2013590 (2007).","journal-title":"Clin. Cancer Res."},{"key":"879_CR225","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1535-7163.MCT-08-0298","volume":"7","author":"JR Kirshner","year":"2008","unstructured":"Kirshner, J. R. et al. Elesclomol induces cancer cell apoptosis through oxidative stress. Mol. Cancer Ther. 7, 2319\u20132327 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"879_CR226","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12951-024-02995-3","volume":"22","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Synergistic SDT\/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms. J. Nanobiotechnol. 22, 762 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"879_CR227","doi-asserted-by":"publisher","first-page":"eadl4018","DOI":"10.1126\/sciadv.adl4018","volume":"10","author":"C Moison","year":"2024","unstructured":"Moison, C. et al. SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia. Sci. Adv. 10, eadl4018 (2024).","journal-title":"Sci. Adv."},{"key":"879_CR228","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ijmm.2023.5343","volume":"53","author":"P Li","year":"2024","unstructured":"Li, P., Sun, Q., Bai, S., Wang, H. & Zhao, L. Combination of the cuproptosis inducer disulfiram and anti-PD-L1 abolishes NSCLC resistance by ATP7B to regulate the HIF-1 signaling pathway. Int. J. Mol. Med. 53, 19 (2024).","journal-title":"Int. J. Mol. Med."},{"key":"879_CR229","doi-asserted-by":"publisher","first-page":"114301","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed. Pharmacother. 159, 114301 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"879_CR230","doi-asserted-by":"publisher","first-page":"108218","DOI":"10.1016\/j.isci.2023.108218","volume":"26","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer. iScience 26, 108218 (2023).","journal-title":"iScience"},{"key":"879_CR231","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.7150\/jca.77445","volume":"13","author":"X Nie","year":"2022","unstructured":"Nie, X., Chen, H., Xiong, Y., Chen, J. & Liu, T. Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1\/lipoic acid pathway activation. J. Cancer 13, 3503\u20133514 (2022).","journal-title":"J. Cancer"},{"key":"879_CR232","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","volume":"42","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer. J. Exp. Clin. Cancer Res. 42, 142 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"879_CR233","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cmdc.201600276","volume":"11","author":"H Siebeneicher","year":"2016","unstructured":"Siebeneicher, H. et al. Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876. ChemMedChem 11, 2261\u20132271 (2016).","journal-title":"ChemMedChem"},{"key":"879_CR234","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.chembiol.2021.10.007","volume":"29","author":"K Olszewski","year":"2022","unstructured":"Olszewski, K. et al. Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors. Cell Chem. Biol. 29, 423\u2013435.e10 (2022).","journal-title":"Cell Chem. Biol."},{"key":"879_CR235","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/sj.cdd.4401466","volume":"11","author":"D Lagadic-Gossmann","year":"2004","unstructured":"Lagadic-Gossmann, D., Huc, L. & Lecureur, V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 11, 953\u2013961 (2004).","journal-title":"Cell Death Differ."},{"key":"879_CR236","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","volume":"154","author":"X Song","year":"2018","unstructured":"Song, X. et al. JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice. Gastroenterology 154, 1480\u20131493 (2018).","journal-title":"Gastroenterology"},{"key":"879_CR237","doi-asserted-by":"publisher","first-page":"111911","DOI":"10.1016\/j.celrep.2022.111911","volume":"42","author":"F Chen","year":"2023","unstructured":"Chen, F., Zhu, S., Kang, R., Tang, D. & Liu, J. ATP6V0D1 promotes alkaliptosis by blocking STAT3-mediated lysosomal pH homeostasis. Cell Rep. 42, 111911 (2023).","journal-title":"Cell Rep."},{"key":"879_CR238","doi-asserted-by":"publisher","first-page":"71","DOI":"10.37349\/etat.2020.00005","volume":"1","author":"C Ward","year":"2020","unstructured":"Ward, C. et al. The impact of tumour pH on cancer progression: strategies for clinical intervention. Explor. Target. Antitumor Ther. 1, 71\u2013100 (2020).","journal-title":"Explor. Target. Antitumor Ther."},{"key":"879_CR239","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2021.05.049","volume":"562","author":"S Zhu","year":"2021","unstructured":"Zhu, S., Liu, J., Kang, R., Yang, M. & Tang, D. Targeting NF-\u03baB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells. Biochem. Biophys. Res. Commun. 562, 55\u201361 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"879_CR240","doi-asserted-by":"publisher","first-page":"109848","DOI":"10.1016\/j.celrep.2021.109848","volume":"37","author":"W Du","year":"2021","unstructured":"Du, W. et al. Lysosomal Zn2+ release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma. Cell Rep. 37, 109848 (2021).","journal-title":"Cell Rep."},{"key":"879_CR241","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/s41589-025-01841-3","volume":"21","author":"W Fu","year":"2025","unstructured":"Fu, W. et al. Persistent activation of TRPM4 triggers necrotic cell death characterized by sodium overload. Nat. Chem. Biol. 21, 1238-1249 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"879_CR242","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.aar4510","volume":"359","author":"HE Autzen","year":"2018","unstructured":"Autzen, H. E. et al. Structure of the human TRPM4 ion channel in a lipid nanodisc. Science 359, 228\u2013232 (2018).","journal-title":"Science"},{"key":"879_CR243","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05740-0","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells. Cell Death Dis. 14, 238 (2023).","journal-title":"Cell Death Dis."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00879-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:01:43Z","timestamp":1784178103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":243,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["879"],"URL":"https:\/\/doi.org\/10.1038\/s41568-025-00879-8","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"10 September 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.G. is an inventor on patent applications involving targeting ferroptosis in cancer therapy and reports personal fees from Guidepoint Global, Cambridge Solutions and NGM Bio. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}